Baselga, J., Bradbury, I., Eidtmann, H., Di Cosimo, S., de Azambuja, E., Aura, C., . . . Piccart-Gebhart, M. (2012). Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): A randomised, open-label, multicentre, phase 3 trial. Lancet.
Chicago ZitierstilBaselga, José, et al. "Lapatinib With Trastuzumab for HER2-positive Early Breast Cancer (NeoALTTO): A Randomised, Open-label, Multicentre, Phase 3 Trial." Lancet 2012.
MLA ZitierstilBaselga, José, et al. "Lapatinib With Trastuzumab for HER2-positive Early Breast Cancer (NeoALTTO): A Randomised, Open-label, Multicentre, Phase 3 Trial." Lancet 2012.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.